Pay in 4 interest-free payments of $5.42 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
No commitment if you decide not to continue
The Tirzepatide Microdose Program is a clinician-guided telehealth program built around low-dose compounded tirzepatide, a dual-action medication that works on two metabolic pathways (GIP and GLP-1) to support appetite control and weight management
Its really important to not use the scale as the only outcome of whether you should stay on this medication
The mechanism is plausible, the animal data is consistent, and there is no reason to take the risk
Research has shown that people who integrate healthy lifestyle factors and maintain those factors are also less likely to regain weight
Others showed that both GLP-1 and DPP-4i limit infarct size in animal models of MI by increasing intracellular cAMP levels and activating PKA (51, 52)
US$ 23.62
US$ 20.14
US$ 22.92
US$ 25.86
US$ 25.90
US$ 23.37
US$ 27.06
US$ 22.14
US$ 27.39
US$ 27.61
US$ 29.31
US$ 29.84
